(4-((4-methylpiperidin-1-yl)sulfonyl)naphthalen-1-yl)boronic acid

Catalog No. :
ACUYNK344
CAS No. :
1704121-04-9
Molecular Formula :
C16H20BNO4S
Molecular Weight :
333.22

IUPAC Name:(4-((4-methylpiperidin-1-yl)sulfonyl)naphthalen-1-yl)boronic acid

(4-((4-methylpiperidin-1-yl)sulfonyl)naphthalen-1-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$430.00Login to see priceInquiryInquiry
1g98%$1078.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-((4-methylpiperidin-1-yl)sulfonyl)naphthalen-1-yl)boronic acid
IUPAC Name(4-((4-methylpiperidin-1-yl)sulfonyl)naphthalen-1-yl)boronic acid
MDL No.MFCD28805581
Molecular FormulaC16H20BNO4S
Molecular Weight333.22
SMILESO=S(C1=C2C=CC=CC2=C(B(O)O)C=C1)(N3CCC(C)CC3)=O
InChI KeyJKKZHTWNWDESDA-UHFFFAOYSA-N
Synonym(4-((4-methylpiperidin-1-yl)sulfonyl)naphthalen-1-yl)boronic acid;Boronic acid, B-[4-[(4-methyl-1-piperidinyl)sulfonyl]-1-naphthalenyl]-
CAS No.1704121-04-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACUYNK344 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUYNK344 route product structure diagram
    ACUYNK3441704121-04-9
Inquiry

2. ACUYNK344 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUYNK344 route product structure diagram
    ACUYNK3441704121-04-9
Inquiry

Comments (0)